Steve Harr (L) and Hans Bishop
Painting by the numbers, Sana founders carve up a giant unicorn-sized IPO — for a biotech that hasn't quite made it to the clinic
Sana Biotechnology is one of those startups that was sketched in on the chalkboard day one in the shape of a unicorn.
A giant …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
